Last reviewed · How we verify

NCT04421066

Histological, Genetic and Epigenetic Analysis of Procedures Related with Dental Implants

Completed Last updated 26 February 2025
What this trial tests

trial testing Gingival and bone sample collection in Peri-Implantitis in 200 participants. Completed in 20 June 2022.

Timeline
29 January 2019
Primary endpoint
21 October 2021
20 June 2022

Quick facts

Lead sponsorSimón Pardiñas López
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date29 January 2019
Primary completion21 October 2021
Estimated completion20 June 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Simón Pardiñas López

Who can join

Adults 20 to 90, any sex, with Peri-Implantitis or Peri-implant Mucositis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study genomic, proteomic and histological technologies for the search and characterization of epigenetic modifications and molecular or protein markers, useful in the diagnosis and progression of peri-implant diseases and prevention of implant failure will be used.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Global DNA Methylation in Dental Implant Failure Due to Peri-Implantitis: An Exploratory Clinical Pilot Study.
    Khouly I, Pardiñas López S, Díaz Prado SM, Ferrantino L, et al · · 2022 · cited 6× · PMID 35055840 · DOI 10.3390/ijerph19021020

Verify or expand the search:

Other recruiting trials for Peri-Implantitis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04421066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing